Anteo Diagnostics Ltd has released a press release.
Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- AnteoTech Secures $3.76M Option Underwriting Agreement
- AnteoTech Developing Multiplex Test for COVID-19
- AnteoTech Advances Battery Technology Program
- AnteoTech and Axxin Build Successful Sepsis Multiplex Test
- R & D Refund Received
Later from AnteoTech
- AnteoTech COVID-19 Antigen Test Progress Update
- AnteoTech Achieve ISO-13485 Certification
- Study Confirms Targeted Sensitivity of COVID-19 Test
- AnteoTech Freeze Design of COVID 19 Test
- $1.19 million R&D Tax Incentive Refund Received
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech